Enzon Pharmaceuticals (ENZN): Price and Financial Metrics
Today's Latest Price: $0.18 USD
Nov 27 9:59pm Add ENZN to Watchlist Sign Up
ENZN Stock Summary The ratio of debt to operating expenses for Enzon Pharmaceuticals Inc is higher than it is for about just 0.52% of US stocks. With a price/sales ratio of 120.11, Enzon Pharmaceuticals Inc has a higher such ratio than 97.26% of stocks in our set. As for revenue growth, note that ENZN's revenue has grown -99.08% over the past 12 months; that beats the revenue growth of merely 0.67% of US companies in our set. If you're looking for stocks that are quantitatively similar to Enzon Pharmaceuticals Inc, a group of peers worth examining would be CVR, DSWL, GURE, RELL, and SIM. ENZN's SEC filings can be seen here. And to visit Enzon Pharmaceuticals Inc's official web site, go to www.enzon.com.
ENZN Price/Volume Stats
ENZN Latest News Stream
All News Types
Loading, please wait...
Latest ENZN News From Around the Web
Below are the latest news stories about Enzon Pharmaceuticals Inc that investors may wish to consider to help them evaluate ENZN as an investment opportunity.
Under the board approved rights offering to existing shareholders, Enzon Pharmaceuticals' (ENZN) seeks to distribute one transferable subscription right for each outstanding share of common stock owned.For every 1,105 subscription rights held, a shareholder will be entitled to purchase one unit.Enzon plans to offer 40K units at a subscription price...
Read More 'ENZN' Stories Here
ENZN Price Returns
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
Page generated in 0.9132 seconds.